Amit Thakral
YOU?
Author Swipe
View article: Improving Hepatitis B Screening Prior to Rituximab: A Quality Improvement Project
Improving Hepatitis B Screening Prior to Rituximab: A Quality Improvement Project Open
Rituximab, used in the treatment of some rheumatic and kidney diseases, can lead to hepatitis B virus (HBV) reactivation; HBV screening is recommended for those starting this medication. We aimed to improve by 50% the proportion of patient…
View article: Neurosarcoidosis in children: A systematic review and summary of cases, imaging and management
Neurosarcoidosis in children: A systematic review and summary of cases, imaging and management Open
View article: Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection
Giant Coronary Aneurysms in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection Open
Multisystem inflammatory syndrome in children (MIS-C) can cause a myriad of cardiac manifestations, including coronary dilation and aneurysms; giant aneurysms are infrequent. We describe 3patients with giant coronary aneurysms associated w…
View article: Pituitary Sarcoidosis in a Pediatric Patient Successfully Treated With Adalimumab and Methotrexate
Pituitary Sarcoidosis in a Pediatric Patient Successfully Treated With Adalimumab and Methotrexate Open
Neurosarcoidosis is a rare phenomenon in the pediatric population, with only a few cases reported in the literature worldwide. While hypothalamo-pituitary involvement is known to occur, direct infiltration of the pituitary gland and isolat…
View article: Acute Hemorrhagic Infancy of Edema: A Purpuric Rash in 6-Month-Old Infant
Acute Hemorrhagic Infancy of Edema: A Purpuric Rash in 6-Month-Old Infant Open
Acute hemorrhagic edema of infancy (AHEI) is a cutaneous leukocytoclastic vasculitis presenting with purpura, ecchymosis, fever, and edema. Pediatricians must effectively differentiate AHEI from other diseases that have similar presentatio…
View article: Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center
Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center Open
Oligoarticular juvenile idiopathic arthritis (JIA) is a common disease in pediatric rheumatology. The management of oligoarticular JIA can result in a considerable economic burden. This study is a four-year, retrospective cost identificati…
View article: An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus
An Update on Treatment and Management of Pediatric Systemic Lupus Erythematosus Open